Serial Number
97051729
Owner
Medalogix LLCAttorney
Edward D. Lanquist, Jr.First Use Date
Jan 13, 2020
Filing Date
Sep 29, 2021
MUSE Trademark
Serial Number: 97051729
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Edward D. Lanquist, Jr. Baker Donelson
1600 West End Avenue, Suite 2000
Nashville, TN 37203
United States
Trademark Details
Filing Date
September 29, 2021
Registration Date
Not Registered
First Use Anywhere
January 13, 2020
First Use in Commerce
January 13, 2020
Goods & Services
Consultation services in the fields of health care, medical, pharmaceutical and population health data, namely, data analytics, namely, data and medical analysis for the treatment of persons at end-of-life, readmission risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, hospitalization risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, predictive modeling, namely, data and medical analysis for the treatment of persons at end-of-life and predictive reporting, namely, data and medical analysis for the treatment of persons at end-of-life; providing health care information; providing health related analytics, namely, readmission risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, hospitalization risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, predictive modeling, namely, data and medical analysis for the treatment of persons at end-of-life and predictive reporting, namely, data and medical analysis for the treatment of persons at end-of-life; providing web-based access to health related analytics, namely, readmission risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, hospitalization risk analysis, namely, data and medical analysis for the treatment of persons at end-of-life, predictive modeling, namely, data and medical analysis for the treatment of persons at end-of-life and predictive reporting, namely, data and medical analysis for the treatment of persons at end-of-life